Effect of Clostridium butyricum on Gastrointestinal Infections.

Biomedicines. February 2022;10(2):.

Tadashi Ariyoshi¹, Mao Hagihara², Motomichi Takahashi³, Hiroshige Mikamo⁴

¹ Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.; ² Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.; ³ Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.; ⁴ Department of Clinical Infectious Diseases, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.

Abstract

Clostridium butyricum is a human commensal bacterium with beneficial effects including butyrate production, spore formation, increasing levels of beneficial bacteria, and inhibition of pathogenic bacteria. Owing to its preventive and ameliorative effects on gastrointestinal infections, C. butyricum MIYAIRI 588 (CBM 588) has been used as a probiotic in clinical and veterinary medicine for decades. This review summarizes the effects of C. butyricum, including CBM 588, on bacterial gastrointestinal infections. Further, the characteristics of the causative bacteria, examples of clinical and veterinary use, and mechanisms exploited in basic research are presented. C. butyricum is widely effective against Clostoridioides difficile, the causative pathogen of nosocomial infections; Helicobacter pylori, the causative pathogen of gastric cancer; and antibiotic-resistant Escherichia coli. Accordingly, its mechanism is gradually being elucidated. As C. butyricum is effective against gastrointestinal infections caused by antibiotics-induced dysbiosis, it can inhibit the transmission of antibiotic-resistant genes and maintain homeostasis of the gut microbiome. Altogether, C. butyricum is expected to be one of the antimicrobial-resistance (AMR) countermeasures for the One-health approach.

Keywords

Clostridioides difficile; Clostridium butyricum; Helicobacter pylori; gastrointestinal infection; gut dysbiosis;

Article Tools:

Medline

Email to me

Archives Highlights:

Top 5 Tips for Interpreting Heartworm Test Results
It is commonly believed that heartworm disease can be diagnosed based on a simple positive or negative in-clinic test result; however, this is not always true when testing dogs and is less accurate in cats. Interpretation of a heartworm antigen test is only one component of an accurate heartworm diagnosis; a variety of testing modalities may be required. Testing for the presence of antigens and microfilariae is recommended in dogs; diagnosis in cats usually requires additional testing (eg, antibody testing, radiography). These are the top 5 scenarios encountered when diagnosing heartworm disease in dogs and cats.

Survey of self-reported radiation safety practices among North American veterinary technicians involved in equine radiography using portable x-ray equipment.
Lead apron use was suboptimal, reported as "always" for 80.0% (104/130) of tube operators and 83.1% (123/148) of cassette holders. Approximately 20% of participants never wore thyroid shields, and approximately 90% never wore lead eyeglasses. Almost 50% of participants did not have lead eyeglasses available. Although > 55% of participants always held the x-ray equipment by hand, 58.4% (73/125) of tube operators and 25.0% (35/140) of cassette holders never wore gloves.

Top 5 Goals for Management of Diabetes Mellitus
Optimal glycemic control can be a moving target in dogs and cats, depending on how control is defined. Studies that examine insulin efficacy and safety use several methods to assess glycemic control, including assessing clinical signs, maintaining glycated proteins in a target range, and determining the insulin time–action profile (ie, glucose curve). Each assessment method has advantages and disadvantages, and no single method is clearly superior.

Insulins for the long term management of diabetes mellitus in dogs: a review.
The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus.

A longitudinal study of the persistence of increased creatinine and concordance between kidney biomarkers in cats and dogs.
The study included 4517 cats and 4576 dogs with increased T1 creatinine concentrations and 54,295 cats and 125,403 dogs with T1 creatinine at or below the URL. The probability of a persistently increased creatinine at T2 was approximately 58% for cats and 49% for dogs after a T1 increase. For animals without a T1 increase the probability of increased creatinine at T2 was only 7% for cats and 3% for dogs. For cats and dogs with persistently increased Cr, the probability of an increased SDMA concentration at T1 was 70-75%. By 24 months, that probability rose to 94% for cats and 88% for dogs.